Pharmaceutical Inc Biomarin, 10% Owner at CATALYST PHARMACEUTICAL PARTNERS, INC. (CPRX), bought 5,000,000 shares at $0.75 ($3.8M) on 2012-12-08, disclosed to the SEC on 2012-12-12.
Open-market purchase of $3.8M CPRX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |